The Effect of Aromatase Inhibition on the Cognitive Function of Older Patients with Breast Cancer

PURPOSE: To evaluate the association between aromatase inhibitor (AI) therapy and cognitive function (over a 6-month time period) in a cohort of patients age ≥ 60 compared with an age-matched healthy control group, and to evaluate changes in regional cerebral metabolism as measured by positron emiss...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Hurria, Arti, Patel, Sunita K., Mortimer, Joanne, Luu, Thehang, Somlo, George, Katheria, Vani, Ramani, Rupal, Hansen, Kurt, Feng, Tao, Chuang, Carolyn, Geist, Cheri L., Silverman, Daniel H.S.
Format: Artigo
Idioma:Inglês
Publicat: 2013
Matèries:
Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC4103787/
https://ncbi.nlm.nih.gov/pubmed/24291380
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.clbc.2013.10.010
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars